Refine your search
Collections
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Maraicar, K. Shahul Hammed
- DHEA: The Remedy for Andropause
Abstract Views :556 |
PDF Views:393
Authors
J. Balasubramanian
1,
K. Shahul Hammed Maraicar
1,
D. Babu Ananth
1,
N. Vijayakumar
1,
R. Dhanalakishmi
1
Affiliations
1 Shield Health Care Pvt Ltd, Chennai-600095, Tamilnadu, IN
1 Shield Health Care Pvt Ltd, Chennai-600095, Tamilnadu, IN
Source
Indian Journal of Medicine and Healthcare, Vol 1, No 2 (2012), Pagination: 29-31Abstract
Andropause is a clinical and biochemical syndrome associated with advancing age in males and mainly characterized by a deficiency in serum (blood) androgen, mostly testosterone, levels. The condition is sometimes referred to as Androgen Decline in the Aging Male (ADAM), Partial Androgen Deficiency in the Aging Male (PADAM) or Aging Associated Androgen Deficiency (AAAD). Although the term andropause is used most often in the scientific literature, it is actually something of a misnomer because androgen releases never fully stops or "pauses" in the majority of aging men. A growing body of research suggests that DHEA can prevent or reverse the diseases that anti-aging experts have identified as the most prominent markers of accelerated aging: atherosclerosis (hardening and clogging o f the arteries), cancer, diabetes, and reduced immunity.Keywords
Androgen Decline, Aging Associated Decline, Aging Associated Androgen DeficiencyFull Text
References
- Alexandersen P, Haarbo J and Christiansen C (1996) The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis. 125(1), 1-13.
- Arlt W (2004) Dehydroepiandrosterone and aging, best practice & research. Clin. endocrinology & metabolism. 18 (3), 363–380.
- Arnlov J, Pencina MJ and Amin S et al. (2006) Endogenous sex hormones and cardiovascular disease incidence in men. Ann. Intern. Med. 145 (3), 176–184.
- Barrett-Connor E, Khaw KT and Yen SS (1986) A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N. Engl. J. Med. 315 (24), 1519–1524.
- Baulieu EE, Thomas G Legrain S et al. (2000) DHEA sulfate, and aging: contribution of the DHEA ge study to a sociobiomedical issue. Proc. Natl. Acad. Sci. USA. 97, 4279-4284.
- Christeff N, Lortholary O and Casassus P et al. (1996) Relationship between sex steroid hormone levels and CD4 lymphocytes in HIV infected men. Exp. Clin. Endocrinol. Diabetes. 104(2),130-136.
- Crosbie D, Black C, McIntyre L, Royle PL and Thomas S (2007) Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane database of systematic rev. (4), CD005114.
- Cunningham SK and McKenna TJ (1994) Dissociation of adrenal androgen and cortisol secretion in Cushing's syndrome. Clin. Endocrinol. 41,795.
- Derksen RH (1998) Dehydroepiandrosterone and systemic lupus erythematosus. Semin. Arthritis Rheum. 27, 335-347.
- Fuller SJ, Tan RS and Martins RN (2007) Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions. J. Alzheimer's disease.12 (2), 129–142.
- Labrie F, Belanger A, et al. (1998) DHEA and the intracrine formatoin of androgens and estrogens in perioheral target tissues: its role during aging. Steroids. 63(5-6), 322-328.
- Longcope C (1996) Dehydroepiandrosterone metabolism. J. Endocrinol. 150(suppl), S125-S127.
- Morales AJ et al. (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endorcrionol. Metab. 78, 1360- 1367.
- Morales AJ, Haubrich RH, Hwang JY et al. (1998) The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. 49, 421-432.
- Orentreich N (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrin. Metabolism. 59,551-555.
- Rabkin JG, Ferrando SJ, Wagner GJ et al. (2000) DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology. 25(1), 53-68.
- Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ and Ferrando SJ (2006) Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am. J. Psychiatry. 163(1), 59-66.
- Roberts E (1999) The importance of dehydroepiandrosterone sulfate in the blood of primates: a longer and healthier life. Biochemical Pharmacol. 57 (4), 329-346.
- Schulman, Robert A, Dean MD and Carolyn, MD (2007) DHEA is a common hormone produced in the adrenal glands, the gonads, and the brain. pp:100.
- Schulz S, Klann RC, Schönfeld S and Nyce JW (1992) Mechanisms of cell growth inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: role of isoprenoid biosynthesis. Cancer Res. 52 (5),1372–1376.
- Thijs L, Fagard R, Forette F, Nawrot T and Staessen JA (2003) Are low dehydro epiandrosterone sulfate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies. Acta. Cardiol. 58(5), 403-410.
- Tummala S and Svec F (1999) Correlation between the administered dose of DHEA and serum levels of DHEA and DHEA-S in human volunteers: analysis of published data. Clin. Biochem. 32, 355-361.
- Van Vollenhoven RF (2000) Dehydroepiandrosterone in systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 26,349- 362.
- Van Vollenhoven RF, Engleman EG and McGuire JL (1995) Dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. 38, 1826-1831.
- VanVollenhover RF and McGuire JL (1994) An open study of DHEA in systemic lupus Erythematosis. Arthritis & Rheumatism. 37(9), 1305-1310. 26. Wyllie M (2003) ADAM and the andropause. Brit. J. Urol. Int.91, 883-884.
- William F and Ganong MD (2005) Review of medical physiology, 22nd Ed, McGraw Hill, 2005, page 362.
- Zumoff BV and Bradlow HL (1980) Sex difference in the metabolism of dehydroepiandrosterone sulfate. J. Clin. Endocrinol. Metab. 51, 334-346.